The deal for acquiring Ranbaxy by Sun Pharmaceuticals Industries is a ‘great move’.

In a statement released here on Monday, Prasad said: “Great move by Sun. Consistent with their strategy of acquiring distressed assets and turning them around.’’

GV Prasad

Chairman and CEO, Dr Reddy’s Laboratories